Can an intrauterine device (IUD) cause anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can an IUD Cause Anemia?

Yes, copper IUDs can cause or worsen anemia through increased menstrual blood loss, while levonorgestrel IUDs actually improve anemia by reducing menstrual bleeding.

Type-Specific Effects on Anemia

Copper IUDs (Cu-IUD)

  • Copper IUDs increase menstrual blood loss, which can precipitate or aggravate iron deficiency anemia 1
  • Studies show that Cu-IUD users experience statistically significant decreases in hemoglobin levels during 12 months of follow-up, though the magnitude is typically small and may not be clinically significant in women without pre-existing anemia 1
  • Serum ferritin levels decline significantly with copper IUD use, indicating depletion of iron stores even when hemoglobin remains stable 2, 3
  • Research demonstrates that 55-70% of long-term copper IUD users develop low ferritin levels (below 11 ng/ml), and 22-26% develop subnormal hematocrit 3, 4
  • The Lippes Loop causes the greatest increase in menstrual blood loss, sustained throughout 24 months of use 3

Levonorgestrel IUDs (LNG-IUD)

  • The LNG-IUD improves anemia markers rather than causing anemia 1
  • Women with iron-deficiency anemia can use the LNG-IUD without restriction (U.S. MEC Category 1) 1
  • The LNG-IUD is beneficial for treating heavy menstrual bleeding (menorrhagia), with evidence showing no increase in adverse effects 5
  • Laboratory improvements include: significant increases in hemoglobin, hematocrit, serum iron, and ferritin levels in women with heavy menstrual bleeding 6
  • Only 2% of long-term LNG-IUD users develop subnormal hematocrit, compared to 22-26% with copper IUDs 4
  • The LNG-IUD reduces menstrual blood loss by 40-50% and increases serum ferritin 3

Clinical Management Algorithm

For Women Considering Copper IUDs:

  • Pre-insertion screening for anemia is not necessary according to U.S. guidelines, as the changes in hemoglobin are generally not clinically significant 1
  • However, women with pre-existing iron deficiency anemia can still use copper IUDs (U.S. MEC Category 2 - generally can use) 1
  • Consider measuring serum ferritin in long-term copper IUD users to identify iron depletion before clinical anemia develops 7

For Women with Heavy Menstrual Bleeding or Anemia:

  • The LNG-IUD is the preferred choice as it treats both the bleeding and improves anemia markers 8, 6
  • The LNG-IUD is particularly useful for women with severe thrombocytopenia who have menorrhagia 5
  • Expect improvement in hemoglobin, hematocrit, serum iron, and ferritin within one year of placement 6

Important Caveats

  • Women in developing countries or with marginal iron stores are at higher risk for clinically significant anemia with copper IUDs 3
  • The risk of anemia is particularly concerning with long-term copper IUD use (beyond 12 months) 2
  • Self-selection bias may underestimate the true risk, as women who develop significant bleeding often discontinue IUD use 7
  • Increased dietary iron absorption may partially compensate for increased menstrual losses in some women 7

References

Research

The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1988

Guideline

u s. medical eligibility criteria for contraceptive use, 2010.

MMWR Recommendations and Reports, 2010

Research

Improvement of laboratory markers of anaemia in the treatment of heavy menstrual bleeding with a 19.5-mg intrauterine device: a pilot study.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2024

Research

Iron-deficiency anemia and long-term use of copper-bearing IUDs.

Contraceptive delivery systems, 1982

Guideline

Benefits of IUDs for Perimenopausal Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What form of iron is best to supplement with for women who menstruate and experience significant blood loss, such as after intrauterine device (IUD) insertion?
In a 46-year-old woman with a history of heavy menstrual bleeding, gastric bypass surgery, and a Mirena intrauterine device, presenting with severe iron-deficiency anemia (hemoglobin 6.4 g/dL, ferritin 2 ng/mL), what is the recommended acute and subsequent management?
What contraceptive option is suitable for a patient with hypertension, heavy menstrual bleeding, and anemia?
In a 41-year-old woman with irregular menses, a copper intrauterine device, low ferritin indicating iron deficiency, and a markedly suppressed TSH with normal free T4, how should I manage iron replacement and what follow-up is recommended for the thyroid labs?
Can stress cause intermenstrual bleeding in a patient with a copper Intrauterine Device (IUD) and a history of Graves' disease?
How should I manage migraines that appear to be triggered by sodium sensitivity?
How should a thickened hyperkeratotic plaque be evaluated and managed?
What is the recommended diagnostic workup and treatment strategy for an adult with suspected polyarteritis nodosa, including management of severe organ‑life‑threatening disease, limited disease, and hepatitis B‑associated cases?
What alternative routes of administration are available for sertraline in a patient who cannot swallow oral tablets?
What is paroxysmal finger hematoma (Achenbach syndrome) and how should it be managed, including red‑flag signs and indications for further investigation?
What are the relapse (flare‑up) rates for bipolar I disorder and major depressive disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.